Cargando…

Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study

BACKGROUND: Post-tuberculosis (post-TB) lung disease is an under-recognised consequence of pulmonary tuberculosis (pTB). We aimed to estimate the prevalence of residual lung function impairment and reduced health-related quality of life (HRQoL) in children after pTB treatment completion. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkereuwem, Esin, Agbla, Schadrac, Sallahdeen, Azeezat, Owolabi, Olumuyiwa, Sillah, Abdou K, Genekah, Monica, Tunkara, Abdoulie, Kandeh, Sheriff, Jawara, Maryama, Saidy, Lamin, Bush, Andrew, Togun, Toyin, Kampmann, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985734/
https://www.ncbi.nlm.nih.gov/pubmed/36109164
http://dx.doi.org/10.1136/thorax-2022-219085
_version_ 1784901021075505152
author Nkereuwem, Esin
Agbla, Schadrac
Sallahdeen, Azeezat
Owolabi, Olumuyiwa
Sillah, Abdou K
Genekah, Monica
Tunkara, Abdoulie
Kandeh, Sheriff
Jawara, Maryama
Saidy, Lamin
Bush, Andrew
Togun, Toyin
Kampmann, Beate
author_facet Nkereuwem, Esin
Agbla, Schadrac
Sallahdeen, Azeezat
Owolabi, Olumuyiwa
Sillah, Abdou K
Genekah, Monica
Tunkara, Abdoulie
Kandeh, Sheriff
Jawara, Maryama
Saidy, Lamin
Bush, Andrew
Togun, Toyin
Kampmann, Beate
author_sort Nkereuwem, Esin
collection PubMed
description BACKGROUND: Post-tuberculosis (post-TB) lung disease is an under-recognised consequence of pulmonary tuberculosis (pTB). We aimed to estimate the prevalence of residual lung function impairment and reduced health-related quality of life (HRQoL) in children after pTB treatment completion. METHODS: We conducted a cross-sectional comparative study of children aged less than 15 years at TB diagnosis who had completed treatment for pTB at least 6 months previously with a comparator group of age-matched children without a history of pTB. Symptoms, spirometry and HRQoL measured with PedsQL scale were collected. Variables associated with lung function impairment were identified through logistic regression models. RESULTS: We enrolled 68 post-TB cases (median age 8.9 (IQR 7.2–11.2) years) and 91 children in the comparison group (11.5 (8.0–13.7) years). Spirometry from 52 (76.5%) post-TB cases and 89 (94.5%) of the comparison group met the quality criteria for acceptability and repeatability. Lung function impairment was present in 20/52 (38.5%) post-TB cases and 15/86 (17.4%) in the comparison group, p=0.009. Previous pTB and a history of chronic cough were significantly associated with the presence of lung function impairment (p=0.047 and 0.006 respectively). Forced expiratory volume in 1 s (FEV(1)), forced vital capacity (FVC) and FEV(1)/FVC z-scores were significantly lower in the post-TB cases compared with the comparison group (p= <0.001, 0.014 and <0.001, respectively). The distribution of the self-reported physical health score, and parent-reported physical, emotional, psychological, social and total HRQoL scores were significantly lower in the post-TB cases compared with the comparison group. CONCLUSIONS: Previous TB in children is associated with significantly impaired lung function and HRQoL.
format Online
Article
Text
id pubmed-9985734
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99857342023-03-06 Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study Nkereuwem, Esin Agbla, Schadrac Sallahdeen, Azeezat Owolabi, Olumuyiwa Sillah, Abdou K Genekah, Monica Tunkara, Abdoulie Kandeh, Sheriff Jawara, Maryama Saidy, Lamin Bush, Andrew Togun, Toyin Kampmann, Beate Thorax Tuberculosis BACKGROUND: Post-tuberculosis (post-TB) lung disease is an under-recognised consequence of pulmonary tuberculosis (pTB). We aimed to estimate the prevalence of residual lung function impairment and reduced health-related quality of life (HRQoL) in children after pTB treatment completion. METHODS: We conducted a cross-sectional comparative study of children aged less than 15 years at TB diagnosis who had completed treatment for pTB at least 6 months previously with a comparator group of age-matched children without a history of pTB. Symptoms, spirometry and HRQoL measured with PedsQL scale were collected. Variables associated with lung function impairment were identified through logistic regression models. RESULTS: We enrolled 68 post-TB cases (median age 8.9 (IQR 7.2–11.2) years) and 91 children in the comparison group (11.5 (8.0–13.7) years). Spirometry from 52 (76.5%) post-TB cases and 89 (94.5%) of the comparison group met the quality criteria for acceptability and repeatability. Lung function impairment was present in 20/52 (38.5%) post-TB cases and 15/86 (17.4%) in the comparison group, p=0.009. Previous pTB and a history of chronic cough were significantly associated with the presence of lung function impairment (p=0.047 and 0.006 respectively). Forced expiratory volume in 1 s (FEV(1)), forced vital capacity (FVC) and FEV(1)/FVC z-scores were significantly lower in the post-TB cases compared with the comparison group (p= <0.001, 0.014 and <0.001, respectively). The distribution of the self-reported physical health score, and parent-reported physical, emotional, psychological, social and total HRQoL scores were significantly lower in the post-TB cases compared with the comparison group. CONCLUSIONS: Previous TB in children is associated with significantly impaired lung function and HRQoL. BMJ Publishing Group 2023-03 2022-09-15 /pmc/articles/PMC9985734/ /pubmed/36109164 http://dx.doi.org/10.1136/thorax-2022-219085 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Tuberculosis
Nkereuwem, Esin
Agbla, Schadrac
Sallahdeen, Azeezat
Owolabi, Olumuyiwa
Sillah, Abdou K
Genekah, Monica
Tunkara, Abdoulie
Kandeh, Sheriff
Jawara, Maryama
Saidy, Lamin
Bush, Andrew
Togun, Toyin
Kampmann, Beate
Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study
title Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study
title_full Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study
title_fullStr Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study
title_full_unstemmed Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study
title_short Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study
title_sort reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in gambian children: a cross-sectional comparative study
topic Tuberculosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985734/
https://www.ncbi.nlm.nih.gov/pubmed/36109164
http://dx.doi.org/10.1136/thorax-2022-219085
work_keys_str_mv AT nkereuwemesin reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT agblaschadrac reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT sallahdeenazeezat reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT owolabiolumuyiwa reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT sillahabdouk reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT genekahmonica reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT tunkaraabdoulie reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT kandehsheriff reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT jawaramaryama reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT saidylamin reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT bushandrew reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT toguntoyin reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy
AT kampmannbeate reducedlungfunctionandhealthrelatedqualityoflifeaftertreatmentforpulmonarytuberculosisingambianchildrenacrosssectionalcomparativestudy